0001171843-15-003431.txt : 20150615 0001171843-15-003431.hdr.sgml : 20150615 20150615160204 ACCESSION NUMBER: 0001171843-15-003431 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150611 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20150615 DATE AS OF CHANGE: 20150615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Conatus Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001383701 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203183915 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36003 FILM NUMBER: 15931218 BUSINESS ADDRESS: STREET 1: 16745 WEST BERNARDO DRIVE STREET 2: Suite 200 CITY: San Diego STATE: CA ZIP: 92127 BUSINESS PHONE: (858) 376-2600 MAIL ADDRESS: STREET 1: 16745 WEST BERNARDO DRIVE STREET 2: Suite 200 CITY: San Diego STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: Conatus Pharmaceuticals Inc DATE OF NAME CHANGE: 20061214 8-K 1 f8k_061515.htm FORM 8-K f8k_061515.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
_____________________
 
FORM 8-K
_____________________
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): June 11, 2015
 
_____________________
 
CONATUS PHARMACEUTICALS INC.
(Exact Name of Registrant as Specified in its Charter)
 
_____________________
 
 
Delaware
  
001-36003
  
20-3183915
(State or Other Jurisdiction
of Incorporation)
  
(Commission
File Number)
  
(IRS Employer
Identification No.)
 
16745 West Bernardo Drive, Suite 200
San Diego, CA
  
92127
(Address of Principal Executive Offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code: (858) 376-2600
 
(Former Name or Former Address, if Changed Since Last Report.)

_____________________
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
Item 5.07.    Submission of Matters to a Vote of Security Holders.
 
Conatus Pharmaceuticals Inc. (the “Company”) held its annual meeting of stockholders on June 11, 2015.  The following is a brief description of each matter voted upon at the meeting and the number of votes cast for, withheld or against, the number of abstentions and the number of broker non-votes with respect to each matter, as applicable.
 
1.  
The election of three nominees to serve as Class II directors for a three-year term to expire at the 2018 annual meeting of stockholders.  The following three Class II directors were re-elected by the votes indicated:
 
 
For
  
Withheld
  
Broker Non-Votes
Daniel L. Kisner, M.D.
9,682,801
  
48,817
  
5,727,420
Louis Lacasse
9,684,146
  
47,472
  
5,727,420
James Scopa
9,680,945
  
50,673
  
5,727,420

 
2.  
The ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015.  The selection was ratified by the votes indicated:
 
For
  
Against
  
Abstain
  
Broker Non-Votes
15,363,192
  
56,246
  
39,600
  
0

 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

Date: June 15, 2015
  
CONATUS PHARMACEUTICALS INC.
     
   
By:
  
/s/ Charles J. Cashion
   
Name:
  
Charles J. Cashion
   
Title:
  
Senior Vice President, Finance,
       
Chief Financial Officer and Secretary